Measuring Preferences for Cost-Utility Analysis

[1]  David Cella,et al.  Eliciting Social Preference Weights for Functional Assessment of Cancer Therapy-Lung Health States , 2006, PharmacoEconomics.

[2]  J. Brazier,et al.  Valuing Health-Related Quality of Life , 2000, PharmacoEconomics.

[3]  David Feeny,et al.  Multi-Attribute Preference Functions , 1995, PharmacoEconomics.

[4]  George W. Torrance,et al.  Multi-Attribute Health Status Classification Systems , 1995, PharmacoEconomics.

[5]  Johan L. Severens,et al.  Economic evaluations of healthcare programmes and decision making , 2012, PharmacoEconomics.

[6]  P. Neumann.  Health utilities in Alzheimer’s disease and implications for cost-effectiveness analysis , 2012, PharmacoEconomics.

[7]  B. Schackman,et al.  How Often Do Sensitivity Analyses for Economic Parameters Change Cost-Utility Analysis Conclusions? , 2012, PharmacoEconomics.

[8]  G. Salkeld.  Valuing health for regulatory cost-effectiveness analysis , 2007 .

[9]  D. Feeny.  As Good As It Gets but Good Enough for Which Applications? , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[10]  Vahram Ghushchyan,et al.  Mapping the EQ-5D Index from the SF-12: US General Population Preferences in a Nationally Representative Sample , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[11]  Patrick W. Sullivan,et al.  Preference-Based EQ-5D Index Scores for Chronic Conditions in the United States , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[12]  D. Fryback,et al.  Report of Nationally Representative Values for the Noninstitutionalized US Adult Population for 7 Health-Related Quality-of-Life Scores , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[13]  Dan Greenberg,et al.  Trends in the measurement of health utilities in published cost-utility analyses. , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[14]  David Parkin,et al.  Is there a case for using visual analogue scale valuations in cost-utility analysis? , 2006, Health economics.

[15]  R. Bourne,et al.  Cost Effectiveness of Revision Total Knee Arthroplasty , 2006, Clinical orthopaedics and related research.

[16]  A. Stiggelbout.  Health State Classification Systems: How Comparable Are Our Cost-Effectiveness Ratios? , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[17]  J. Brazier,et al.  Mapping between Visual Analogue Scale and Standard Gamble data; results from the UK Health Utilities Index 2 valuation survey. , 2006, Health economics.

[18]  D. Fryback,et al.  Relative Disutilities of 47 Risk Factors and Conditions Assessed with Seven Preference-Based Health Status Measures in a National U.S. Sample: Toward Consistency in Cost-Effectiveness Analyses , 2006, Medical care.

[19]  J. Pliskin,et al.  Using Health State Classification Systems for Utility Elicitation in the Elderly , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[20]  H. Sintonen,et al.  Use of quality-adjusted life years for the estimation of effectiveness of health care: A systematic literature review , 2006, International Journal of Technology Assessment in Health Care.

[21]  Aki Tsuchiya,et al.  Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets. , 2006, Journal of health economics.

[22]  Oliver Rivero-Arias,et al.  Estimating the Association between SF-12 Responses and EQ-5D Utility Values by Response Mapping , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[23]  Douglas K Owens,et al.  Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions from an American College of Chest Physicians task force. , 2006, Chest.

[24]  M. Sperling,et al.  Validity and Responsiveness of Generic Preference-based HRQOL Instruments in Chronic Epilepsy , 2006, Quality of Life Research.

[25]  S. Hill,et al.  Drug prices and value for money: the Australian Pharmaceutical Benefits Scheme. , 2005, JAMA.

[26]  Steven D Pearson,et al.  Quality, innovation, and value for money: NICE and the British National Health Service. , 2005, JAMA.

[27]  K. Thorpe.  The rise in health care spending and what to do about it. , 2005, Health affairs.

[28]  D. Feeny,et al.  Self-Reported Health Status of the General Adult U.S. Population as Assessed by the EQ-5D and Health Utilities Index , 2005, Medical care.

[29]  S. Petrou,et al.  An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. , 2005, Health economics.

[30]  Jill Carlton,et al.  The impact of age-related macular degeneration on health status utility values. , 2005, Investigative ophthalmology & visual science.

[31]  P. A. Kelly,et al.  Valuation of Arthritis Health States Across Ethnic Groups and Between Patients and Community Members , 2005, Medical care.

[32]  J. Nicholl,et al.  Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain. , 2005, Health technology assessment.

[33]  W. Furlong,et al.  Methodology and measurement properties of health-related quality of life instruments: A prospective study of patients undergoing breast reduction surgery , 2005, Health and quality of life outcomes.

[34]  P. Glassman,et al.  The Evolving Use of Cost-Effectiveness Analysis in Formulary Management Within the Department of Veterans Affairs , 2005, Medical care.

[35]  B. Luce.  What will it take to make cost-effectiveness analysis acceptable in the United States? , 2005, Medical care.

[36]  Vahram Ghushchyan,et al.  A National Catalog of Preference-Based Scores for Chronic Conditions in the United States , 2005, Medical care.

[37]  Mark Sculpher,et al.  Common Methodological Flaws in Economic Evaluations , 2005, Medical care.

[38]  J. Brazier,et al.  Utility Scores for the Health Utilities Index Mark 2: An Empirical Assessment of Alternative Mapping Functions , 2005, Medical care.

[39]  A. Pickard,et al.  Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm? , 2005, Health and quality of life outcomes.

[40]  D. Fryback.  A US valuation of the EQ-5D. , 2005, Medical care.

[41]  A. Davis,et al.  A comparison of the quality of life of hearing-impaired people as estimated by three different utility measures Un comparación de la calidad de vida de personas con trastornos auditivos estimada por tres diferentes medidas de utilidad , 2005, International journal of audiology.

[42]  Stephen Joel Coons,et al.  US Valuation of the EQ-5D Health States: Development and Testing of the D1 Valuation Model , 2005, Medical care.

[43]  P. Neumann,et al.  The impact of Medicare modernization on coverage policy: recommendations for reform. , 2005, The American journal of managed care.

[44]  Nan Luo,et al.  Valuations of EQ-5D Health States: Are the United States and United Kingdom Different? , 2005, Medical care.

[45]  T. Ganiats,et al.  Comparison of Measured Utility Scores and Imputed Scores From the SF-36 in Patients With Rheumatoid Arthritis , 2005, Medical care.

[46]  N. Olchanski,et al.  Growth and quality of the cost-utility literature, 1976-2001. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[47]  K. Pietz,et al.  Setting a new standard for studies of geographic variation in hospital utilization rates. , 2005, Medical care.

[48]  G. Gazelle,et al.  Medicare's national coverage decisions, 1999-2003: quality of evidence and review times. , 2005, Health affairs.

[49]  T. Tosteson,et al.  Comparison of EQ-5D, HUI, and SF-36-derived societal health state values among Spine Patient Outcomes Research Trial (SPORT) participants , 2005, Quality of Life Research.

[50]  K. Stavem,et al.  Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS , 2005, Quality of Life Research.

[51]  Y. Asada.  Medical technologies, nonhuman aids, human assistance, and environmental factors in the assessment of health states , 2005, Quality of Life Research.

[52]  D. Feeny,et al.  Responsiveness of generic health-related quality of life measures in stroke , 2005, Quality of Life Research.

[53]  J. Fisk,et al.  A comparison of health utility measures for the evaluation of multiple sclerosis treatments , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[54]  Andrea Manca,et al.  Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. , 2004, Health economics.

[55]  David Feeny,et al.  Comparing Short Form 6D, Standard Gamble, and Health Utilities Index Mark 2 and Mark 3 utility scores: Results from total hip arthroplasty patients , 2004, Quality of Life Research.

[56]  W. Taylor,et al.  Self-Valuation and Societal Valuations of Health State Differ With Disease Severity in Chronic and Disabling Conditions , 2004, Medical care.

[57]  P. Mohr,et al.  Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores , 2004, Schizophrenia Research.

[58]  J. Kopec,et al.  A Comparison of Four Indirect Methods of Assessing Utility Values in Rheumatoid Arthritis , 2004, Medical care.

[59]  M. Drummond,et al.  Inclusion of cost effectiveness in licensing requirements of new drugs : The fourth hurdle , 2017 .

[60]  A. Stiggelbout,et al.  Correcting Biases in Standard Gamble and Time Tradeoff Utilities , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.

[61]  J. Brazier,et al.  The Estimation of a Preference-Based Measure of Health From the SF-12 , 2004, Medical care.

[62]  N. Sengupta,et al.  Mapping the SF-12 to the HUI3 and VAS in a Managed Care Population , 2004, Medical care.

[63]  J. Brazier,et al.  A comparison of the EQ-5D and SF-6D across seven patient groups. , 2004, Health economics.

[64]  J. Brazier,et al.  Comparison of the HUI3 with the SF-36 preference based SF-6D in a clinical trial setting. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[65]  G. Andrews,et al.  Using the effect size to model change in preference values from descriptive health status , 2004, Quality of Life Research.

[66]  R. Holland,et al.  Assessing quality of life in the elderly: a direct comparison of the EQ-5D and AQoL. , 2004, Health economics.

[67]  Ross D Crosby,et al.  Estimating a preference-based single index for the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) instrument from the SF-6D. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[68]  Haomiao Jia,et al.  Mapping the SF-12 to the EuroQol EQ-5D Index in a National US Sample , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.

[69]  M. Weinstein,et al.  When does quality-adjusting life-years matter in cost-effectiveness analysis? , 2004, Health economics.

[70]  S. Tunis.  Economic analysis in healthcare decisions. , 2004, The American journal of managed care.

[71]  B. Bloom.  Use of formal benefit/cost evaluations in health system decision making. , 2004, The American journal of managed care.

[72]  P. Neumann.  Why don't Americans use cost-effectiveness analysis? , 2004, The American journal of managed care.

[73]  David Parkin,et al.  Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. , 2004, Health economics.

[74]  William F Lawrence,et al.  Predicting EuroQoL EQ-5D Preference Scores from the SF-12 Health Survey in a Nationally Representative Sample , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.

[75]  David Feeny,et al.  Comparing directly measured standard gamble scores to HUI2 and HUI3 utility scores: group- and individual-level comparisons. , 2004, Social science & medicine.

[76]  D. Fryback,et al.  Understanding differences between self-ratings and population ratings for health in the EuroQOL , 2003, Quality of Life Research.

[77]  P. Erickson,et al.  Evaluation of a population-based measure of quality of life: the Health and Activity Limitation Index (HALex) , 1998, Quality of Life Research.

[78]  Peter J Neumann,et al.  Evidence-based and value-based formulary guidelines. , 2004, Health affairs.

[79]  P. Neumann.  Evidence-based and value-based formulary guidelines: The movement toward formulary guidelines reflects the larger trend toward evidence-based decision making in medicine , 2004 .

[80]  J. Bosch,et al.  Comparison of the Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication , 2004, Quality of Life Research.

[81]  Stirling Bryan,et al.  An empirical comparison of EQ-5D and SF-6D in liver transplant patients. , 2003, Health economics.

[82]  D. Feeny,et al.  A Comparison of the Health Utilities Indices Mark 2 and Mark 3 in Type 2 Diabetes , 2003, Medical decision making : an international journal of the Society for Medical Decision Making.

[83]  Marthe R. Gold,et al.  Mapping the SF-12 to Preference-Based Instruments: Convergent Validity in a Low-Income, Minority Population , 2003, Medical care.

[84]  John Brazier,et al.  A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index. , 2003, Health economics.

[85]  J. Thumboo,et al.  A comparison of the EuroQol-5D and the Health Utilities Index mark 3 in patients with rheumatic disease. , 2003, The Journal of rheumatology.

[86]  S. Sullivan,et al.  Comparison of Directly Elicited Preferences to Preferences Derived from the SF-36 in Adults with Asthma , 2003, Medical decision making : an international journal of the Society for Medical Decision Making.

[87]  M. Suarez‐Almazor,et al.  Variation in the Estimation of Quality‐adjusted Life‐years by Different Preference‐based Instruments , 2003, Medical care.

[88]  M. Dickson,et al.  Survey of Pharmacoeconomic Assessment Activity in Eleven Countries , 2003 .

[89]  Jacek A Kopec,et al.  A comparative review of four preference-weighted measures of health-related quality of life. , 2003, Journal of clinical epidemiology.

[90]  D. Feeny,et al.  COMPARING COMMUNITY-PREFERENCE–BASED AND DIRECT STANDARD GAMBLE UTILITY SCORES: EVIDENCE FROM ELECTIVE TOTAL HIP ARTHROPLASTY , 2003, International Journal of Technology Assessment in Health Care.

[91]  Paul Kind,et al.  Measuring Population Health: A Comparison Of Three Generic Health Status Measures , 2003, Medical care.

[92]  Murray Krahn,et al.  Patient and Community Preferences for Outcomes in Prostate Cancer: Implications for Clinical Policy , 2003, Medical care.

[93]  E. Halpern,et al.  Comparison of Preference-Based Utilities of the Short-Form 36 Health Survey and Health Utilities Index before and after Treatment of Patients with Intermittent Claudication , 2002, Medical decision making : an international journal of the Society for Medical Decision Making.

[94]  H. Woo,et al.  A comparison of techniques for eliciting patient preferences in patients with benign prostatic hyperplasia. , 2002, The Journal of urology.

[95]  J. Pliskin,et al.  PREFERENCE-BASED OUTCOME MEASURES IN COST-UTILITY ANALYSES , 2002, International Journal of Technology Assessment in Health Care.

[96]  H. Bleichrodt.  A new explanation for the difference between time trade-off utilities and standard gamble utilities. , 2002, Health economics.

[97]  Jennifer Roberts,et al.  Modelling Valuations for Eq-5d Health States: An Alternative Model Using Differences in Valuations , 2002, Medical care.

[98]  J. Brazier,et al.  The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.

[99]  R. Cummins,et al.  Assessing quality of life in the elderly , 2002 .

[100]  R. Deyo,et al.  The practicality and validity of directly elicited and SF-36 derived health state preferences in patients with low back pain. , 2002, Health economics.

[101]  N. Duan,et al.  Can Utility-Weighted Health-Related Quality-of-Life Estimates Capture Health Effects of Quality Improvement for Depression? , 2001, Medical care.

[102]  P J Neumann,et al.  An Off-the-Shelf Help List , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.

[103]  K. Stavem,et al.  Properties of the 15D and EQ-5D utility measures in a community sample of people with epilepsy , 2001, Epilepsy Research.

[104]  J Hjelmgren,et al.  Health economic guidelines--similarities, differences and some implications. , 2001, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[105]  P. Kind,et al.  A Comparison of United Kingdom and Spanish General Population Time Trade-off Values for EQ-5D Health States , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.

[106]  G. Hawthorne,et al.  A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments , 2001, Annals of medicine.

[107]  D. Voaklander,et al.  The effect of different Euroqol weights on potential qalys gained in patients with hip and knee replacement , 2001 .

[108]  R. Willke,et al.  A comparison of scoring weights for the EuroQol derived from patients and the general public. , 2001, Health economics.

[109]  M. Weinstein,et al.  A Comparison of HU12 and HU13 Utility Scores in Alzheimer's Disease , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.

[110]  C. Bell,et al.  A Comprehensive League Table of Cost-Utility Ratios and a Sub-table of "Panel-worthy" Studies , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.

[111]  M. Suarez‐Almazor,et al.  Use of health status measures in patients with low back pain in clinical settings. Comparison of specific, generic and preference-based instruments. , 2000, Rheumatology.

[112]  H. Sintonen,et al.  Comparison of Finnish and U.S.-based Visual Analog Scale Valuations of the EQ-5D Measure , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.

[113]  C. Sherbourne,et al.  Estimation of utilities for the effects of depression from the SF-12. , 2000, Medical care.

[114]  Tammy O. Tengs,et al.  One thousand health-related quality-of-life estimates. , 2000, Medical care.

[115]  F. D. de Charro,et al.  Sensitivity and perspective in the valuation of health status: whose values count? , 2000, Health economics.

[116]  M. Weinstein,et al.  Preference-based measures in economic evaluation in health care. , 2000, Annual review of public health.

[117]  J. Brazier,et al.  Valuing health-related quality of life. A review of health state valuation techniques. , 2000, PharmacoEconomics.

[118]  J. Brazier,et al.  A Review of the Use of Health Status Measures in Economic Evaluation , 1999, Journal of health services research & policy.

[119]  S. Gabriel,et al.  Health-related Quality of Life in Economic Evaluations for Osteoporosis , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.

[120]  M Johannesson,et al.  The Relationship between Health-state Utilities and the SF-12 in a General Population , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.

[121]  A. Shmueli,et al.  Subjective Health Status and Health Values in the General Population , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.

[122]  J. L. Pinto,et al.  Incorporating societal concerns for fairness in numerical valuations of health programmes. , 1999, Health economics.

[123]  P. Dolan.  Valuing health-related quality of life. Issues and controversies. , 1999, PharmacoEconomics.

[124]  R M Kaplan,et al.  The Quality of Well-Being Scale: critical similarities and differences with SF-36. , 1998, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[125]  J. Brazier,et al.  Deriving a preference-based single index from the UK SF-36 Health Survey. , 1998, Journal of clinical epidemiology.

[126]  D. Fryback,et al.  Toward consistency in cost-utility analyses: using national measures to create condition-specific values. , 1998, Medical care.

[127]  W. Kuipers,et al.  Intermittent claudication: symptom severity versus health values. , 1998, Journal of vascular surgery.

[128]  P. Dolan,et al.  Modeling valuations for EuroQol health states. , 1997, Medical care.

[129]  G. Torrance.  Preferences for health outcomes and cost-utility analysis. , 1997, The American journal of managed care.

[130]  W F Lawrence,et al.  Predicting Quality of Well-being Scores from the SF-36 , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[131]  M. Gold.  Cost-effectiveness in health and medicine , 2016 .

[132]  R. Brooks.  EuroQol: the current state of play. , 1996, Health policy.

[133]  M. Gold,et al.  Assessing the health of the nation. The predictive validity of a preference-based measure and self-rated health. , 1996, Medical care.

[134]  R. Elvik.  The validity of using health state indexes in measuring the consequences of traffic injury for public health. , 1995, Social science & medicine.

[135]  G W Torrance,et al.  Multi-attribute health status classification systems. Health Utilities Index. , 1995, PharmacoEconomics.

[136]  G W Torrance,et al.  Multi-attribute preference functions. Health Utilities Index. , 1995, PharmacoEconomics.

[137]  E. Nord.  Toward Quality Assurance in QALY Calculations , 1993, International Journal of Technology Assessment in Health Care.

[138]  R. Robinson.  Economic Evaluation and Health Care Cost-effectiveness analysis , 2006 .

[139]  R. Klein,et al.  The Beaver Dam Health Outcomes study , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[140]  D A Redelmeier,et al.  Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis. , 1992, Journal of clinical epidemiology.

[141]  E. Nord,et al.  Methods for quality adjustment of life years. , 1992, Social science & medicine.

[142]  R. Kane,et al.  Methodology for measuring health-state preferences--II: Scaling methods. , 1989, Journal of clinical epidemiology.

[143]  R M Kaplan,et al.  A general health policy model: update and applications. , 1988, Health services research.

[144]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .

[145]  G. Torrance.  Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.

[146]  J. Ware,et al.  Choosing measures of health status for individuals in general populations. , 1981, American journal of public health.

[147]  R. Keeney.  A Group Preference Axiomatization with Cardinal Utility , 1976 .